The Casein kinase II (CK2) inhibitor CX-4945 has an additive effect with gemcitabine and cisplatin on cholangiocarcinoma (CCA) cell lines mediated in part through PI3K/Akt inhibition
HEPATOLOGY(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
HEPATOLOGY(2015)